Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Referred to one or more standing committees for review, hearings, and possible markup.
Specific committees not parsed from action data.
The committee may hold hearings, amend the bill, or let it die without action.
Next: Reported
Full chamber floor — Speaker / Majority Leader controls scheduling
Bill to improve access and insurance coverage for HIV prevention medication PrEP.
The problem
Many Americans cannot afford PrEP medication for HIV prevention due to high costs and inconsistent insurance coverage. People at risk lack consistent access.
The proposal
The bill would work to expand insurance coverage requirements for PrEP drugs and improve access programs. It likely includes copayment assistance and coverage mandates.
The impact
People at high risk for HIV, insurance companies, and healthcare providers would be affected. Better access could prevent infections while raising healthcare costs.
More affordable PrEP access means more at-risk people can use proven prevention. This reduces new HIV cases and improves public health. Prevention is more cost-effective than treating HIV long-term.
People with low income or underinsured status face the biggest barriers to PrEP. This bill helps ensure cost is not a reason someone cannot get prevention medication.
Different insurance plans currently cover PrEP differently. A consistent national standard makes it simpler for patients and doctors to understand benefits.
Preventing HIV infection costs less than paying for HIV treatment over a lifetime. This could reduce overall healthcare spending despite upfront PrEP costs.
Mandating PrEP coverage may raise insurance premiums for all customers. Insurers pass these costs to employers and individuals through higher monthly payments.
Easier access might lead to unnecessary prescriptions for people with minimal HIV risk. This raises costs and medication side effect concerns for those who don't need it.
The bill restricts insurance company business decisions by forcing PrEP coverage. Some argue government should not mandate specific drug coverage requirements.
Insurance companies and doctors need time to adapt to new requirements. Transition issues could delay coverage for some patients initially.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Individual contributions, grouped by employer · FEC
Where their individual donors work · 2026 cycle
Money from people who work there, not from the company. Not tied to this bill.
Itemized individual contributions via FEC, grouped by the employer each contributor self-reported. Companies and unions cannot contribute to federal candidates from their treasuries, so these totals are money from people who work at an employer — never from the organization itself. They are campaign contributions covering a full election cycle and are not connected to this bill.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.